Equities researchers at StockNews.com initiated coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the stock.
Streamline Health Solutions Stock Performance
Streamline Health Solutions stock opened at $0.42 on Tuesday. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.76 and a quick ratio of 0.76. The stock has a fifty day moving average price of $0.48 and a two-hundred day moving average price of $0.44. Streamline Health Solutions has a 52-week low of $0.21 and a 52-week high of $1.32. The firm has a market capitalization of $26.05 million, a P/E ratio of -1.31 and a beta of 1.60.
Streamline Health Solutions (NASDAQ:STRM – Get Free Report) last announced its earnings results on Tuesday, June 11th. The company reported ($0.05) earnings per share for the quarter. Streamline Health Solutions had a negative net margin of 85.83% and a negative return on equity of 35.69%. The business had revenue of $4.33 million during the quarter.
Institutional Trading of Streamline Health Solutions
Hedge funds and other institutional investors have recently made changes to their positions in the business. Nicholas Hoffman & Company LLC. increased its stake in shares of Streamline Health Solutions by 10.9% in the fourth quarter. Nicholas Hoffman & Company LLC. now owns 740,983 shares of the company’s stock valued at $315,000 after buying an additional 72,993 shares in the last quarter. Austin Wealth Management LLC increased its position in Streamline Health Solutions by 100.2% in the fourth quarter. Austin Wealth Management LLC now owns 935,519 shares of the company’s stock worth $402,000 after purchasing an additional 468,242 shares during the period. Cerity Partners LLC acquired a new stake in Streamline Health Solutions in the fourth quarter worth about $128,000. Mesirow Financial Investment Management Inc. acquired a new stake in Streamline Health Solutions in the first quarter worth about $59,000. Finally, Vanguard Group Inc. increased its position in Streamline Health Solutions by 1.6% in the third quarter. Vanguard Group Inc. now owns 1,688,305 shares of the company’s stock worth $1,633,000 after purchasing an additional 26,201 shares during the period. 31.74% of the stock is currently owned by institutional investors and hedge funds.
About Streamline Health Solutions
(Get Free Report)
Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.
See Also
Receive News & Ratings for Streamline Health Solutions Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Streamline Health Solutions and related companies with MarketBeat.com’s FREE daily email newsletter.
link